IRAB — Iris Acquisition II Balance Sheet
0.000.00%
- $219.09m
- $219.17m
Annual balance sheet for Iris Acquisition II, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | 10-K |
| Standards: | — | USG |
| Status: | Final | Final |
| Other Long Term Assets | ||
| Total Assets | — | 0.14 |
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Current Liabilities | — | 0.183 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Liabilities | — | 0.183 |
| Non Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Other Equity | ||
| Total Equity | — | -0.043 |
| Total Liabilities & Shareholders' Equity | — | 0.14 |
| Total Common Shares Outstanding |